FiercePharmaAsia—Japan COVID-19 vax deals; Samsung Biologics’ $2B super plant; Eisai’s new U.S. HQ

FiercePharmaAsia—Japan COVID-19 vax deals; Samsung Biologics’ $2B super plant; Eisai’s new U.S. HQ
aliu
Fri, 08/14/2020 – 08:55